Travere Therapeutics Inc (TVTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TVTX? Forum Prognose Aktiensplit

Finanzdaten der Travere Therapeutics Inc-Aktie (TVTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.33% 129.69	164.86	114.45	81.73	62.90
Cost Of Revenue	61.07% 2.553	1.585	1.521	4.679	1.626
Gross Profit	22.13% 127.14	163.27	112.93	77.05	61.27
Operating Expenses	15.34% 159.56	138.34	125.58	119.73	117.42
Benefits Costs and Expenses	8.34% 150.75	139.15	127.18	122.92	117.73
Costs And Expenses	15.86% 162.12	139.93	127.10	124.41	119.05
Operating Income/Loss	230.07% -32.43	24.93	-12.65	-42.67	-56.15
Nonoperating Income/Loss	1,351% 11.36	0.783	-0.085	1.487	1.313
Income/Loss From Continuing Operations Before Tax	181.92% -21.07	25.71	-12.73	-41.19	-54.84
Income Tax Expense/Benefit	11,412% 0.921	0.008	0.02	0.039	-0.084
Income/Loss From Continuing Operations After Tax	185.53% -21.99	25.71	-12.76	-41.23	-54.75
Income/Loss From Discontinued Operations, Net Of Tax	24.71	-	-	-	-0.059
Net Income/Loss	89.38% 2.729	25.71	-12.76	-41.23	-54.81
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.59% 0.3646	89.23	88.95	88.36	77.78
Diluted Average Shares	99.64% 0.3646	102.62	88.95	88.36	77.78
Basic Earnings Per Share	89.66% 0.03	0.29	-0.14	-0.47	-0.70
Diluted Earnings Per Share	89.29% 0.03	0.28	-0.14	-0.47	-0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%